The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a gain of 16.13%.However, over the last six months, we can see a weaker performance of 1.41%. Over the last 30 days, the price of AKBA has fallen by 17.07%. And in the last five days, it has surged by 3.23%.
Akebia Therapeutics Inc. saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $2.48 on 03/28/24, while the lowest price for the same duration was marked at $0.78 on 10/26/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of AKBA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Akebia Therapeutics Inc.’s current trading price is -41.94% away from its 52-week high, while its distance from the 52-week low is 84.59%. The stock’s price range during this period has varied between$0.78 and $2.48. The Akebia Therapeutics Inc.’s shares, which operate in the Healthcare, saw a trading volume of around 1.14 million for the day, a figure considerably lower than their average daily volume of 2.82 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Akebia Therapeutics Inc. (AKBA) has experienced a quarterly rise of 29.73% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 302.82M and boasts a workforce of 167 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.2470, with a change in price of +0.0500. Similarly, Akebia Therapeutics Inc. recorded 2,738,387 in trading volume during the last 100 days, posting a change of +3.60%.
AKBA Stock Stochastic Average
As of today, Akebia Therapeutics Inc.’s raw stochastic average for the last 50 days stands at 79.10%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 54.84%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 63.02% and 61.00%, respectively.
